BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28152507)

  • 1. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
    Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
    Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
    Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
    Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
    Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
    Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma.
    Liu F; Karube K; Kato H; Arita K; Yoshida N; Yamamoto K; Tsuzuki S; Kim W; Ko YH; Seto M
    Int J Clin Exp Pathol; 2012; 5(5):436-41. PubMed ID: 22808296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.
    Hyeon J; Lee B; Shin SH; Yoo HY; Kim SJ; Kim WS; Park WY; Ko YH
    Mod Pathol; 2018 Sep; 31(9):1418-1428. PubMed ID: 29765142
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jangam D; Sridhar K; Butzmann A; Samghabadi P; Plowey ED; Ohgami RS
    Curr Eye Res; 2020 Dec; 45(12):1583-1589. PubMed ID: 32339039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.
    Johansson P; Klein-Hitpass L; Grabellus F; Arnold G; Klapper W; Pförtner R; Dührsen U; Eckstein A; Dürig J; Küppers R
    Oncotarget; 2016 Sep; 7(38):62627-62639. PubMed ID: 27566587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
    van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
    Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.
    Magistri M; Happ LE; Ramdial J; Lu X; Stathias V; Kunkalla K; Agarwal N; Jiang X; Schürer SC; Dubovy SR; Chapman JR; Vega F; Dave S; Lossos IS
    Cancer Res Commun; 2021 Oct; 1(1):1-16. PubMed ID: 35528192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing identifies recurrent
    Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
    Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
    Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.
    Gonzalez-Aguilar A; Idbaih A; Boisselier B; Habbita N; Rossetto M; Laurenge A; Bruno A; Jouvet A; Polivka M; Adam C; Figarella-Branger D; Miquel C; Vital A; Ghesquières H; Gressin R; Delwail V; Taillandier L; Chinot O; Soubeyran P; Gyan E; Choquet S; Houillier C; Soussain C; Tanguy ML; Marie Y; Mokhtari K; Hoang-Xuan K
    Clin Cancer Res; 2012 Oct; 18(19):5203-11. PubMed ID: 22837180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.
    Moody S; Escudero-Ibarz L; Wang M; Clipson A; Ochoa Ruiz E; Dunn-Walters D; Xue X; Zeng N; Robson A; Chuang SS; Cogliatti S; Liu H; Goodlad J; Ashton-Key M; Raderer M; Bi Y; Du MQ
    J Pathol; 2017 Sep; 243(1):3-8. PubMed ID: 28682481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-κB pathway.
    Chen SP; Yang Q; Wang CJ; Zhang LJ; Fang Y; Lei FY; Wu S; Song LB; Guo X; Guo L
    Mol Cancer; 2014 Aug; 13():195. PubMed ID: 25145705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB deregulation in splenic marginal zone lymphoma.
    Spina V; Rossi D
    Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
    Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
    Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
    Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
    Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct involvement of NF-κB regulators by somatic mutation in ocular adnexal malt lymphoma.
    Yan Q; Wang M; Moody S; Xue X; Huang Y; Bi Y; Du MQ
    Br J Haematol; 2013 Mar; 160(6):851-4. PubMed ID: 23240725
    [No Abstract]   [Full Text] [Related]  

  • 19. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
    Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ
    J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
    Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
    J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.